NCT02101788

Clinical Trial Information


Trial Number: NCT02101788 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A randomized phase II/III study to assess the efficacy of trametinib (GSK 1120212) in patients with recurrent or progressive low-grade serous ovarian cancer or peritoneal cancer.
Study ID:
GOG-0281
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial